A genetic association study was conducted to assess whether genetically determined alterations of the nitric oxide system are associated with clinical markers of preeclampsia. A large number of Caucasian women were consecutively included after delivery and genotyped for the endothelial nitric oxide synthase gene (NOS3) polymorphisms G894T, T789C (n ¼ 1502) and intron 4a/b (n ¼ 2186). There are no significant differences in mean blood pressure (BP), protein excretion or new-onset peripheral oedema between any of the genotypes over the course of pregnancy. Neither particular haplotypes nor the combined presence of any two alleles is associated with those markers of pre-eclampsia. The maternal polymorphisms do not seem to influence fetal growth, birth weight or the incidence of congenital malformations. We demonstrate in a large Caucasian population that maternal polymorphisms of the NOS3 gene are not related to clinical markers of pre-eclampsia. The functional relevance of the NOS3 variants alone does not seem to be strong enough to affect BP regulation during pregnancy.
Introduction
Hypertensive disorders of pregnancy contribute significantly to maternal and neonatal morbidity and mortality. They are multifactorial traits resulting from interactions between a variety of genetic and environmental factors. Genetic studies to date have focused on genes involved in haemodynamic control, thrombophilia, oxidative stress and immunological factors.
Nitric oxide (NO) synthase activity has been reported to be increased in various maternal tissues during normal pregnancy. 1 Long-term NO synthase inhibition produces a pre-eclampsia-like syndrome. 2 Polymorphisms of the endothelial NO synthase gene (NOS3), which impair NO availability, have been suspected to contribute to increased predisposition to hypertensive disorders of pregnancy. NO produced by endothelial NO synthase inhibits platelet activation and represents a crucial modulator for the maintenance of maternal systemic vasodilatation and reduced vascular reactivity seen during normal pregnancy. 3, 4 A reduction of placental endothelial NO synthase activity has been demonstrated in pre-eclampsia. 5, 6 Locally generated NO might be needed to promote cytotrophoblast endovascular invasion, which is impaired in preeclampsia.
The common NOS3 G894T or Glu298Asp exon 7 variant (rs1799983) is associated with reduced basal NO production. 7 It has been linked to reduced flow-mediated dilatation of the brachial artery during pregnancy 8 and impaired maternal-fetal circulation. 9 The T786C polymorphism (rs2070744), localized in the NOS3 promoter region, is associated with reduced promoter activity, less placental mRNA and lower serum nitrite/nitrate concentrations. 10, 11 The functional relevance of the variable number of tandem repeats polymorphism in intron 4 (VNTR 4a/b) is unclear. There are conflicting reports on variations in NO and nitrite/nitrate plasma levels. 12, 13 Clinically, a weak association of the three polymorphisms with coronary artery disease has been demonstrated in a meta-analysis. 14 Associations with hypertension and other cardiovascular diseases are in question. 14 A number of case-control studies have been performed to identify possible associations between the NOS3 polymorphisms and hypertensive disorders of pregnancy. As shown in Table 1 , results of these studies are conflicting, in part possibly due to different ethnicity and sample size.
In this study, we chose an alternative approach that has been used previously by our group. 21, 22 As a single polymorphism most probably accounts only for a small part of the multifactorial pathogenesis of hypertensive disorders of pregnancy, it may be hard to detect its effect when focusing on binary end points such as gestational hypertension or preeclampsia. In contrast, the analysis of markers such as blood pressure (BP) elevation, protein excretion and oedema during pregnancy might be able to detect small but significant genetic effects. A large number of cases were included to focus on clinically measurable effects in a population of women with mostly normal pregnancies.
Our group proposed the 'advanced fetal programming hypothesis', postulating that maternal genetic and epigenetic factors or the combination of both results in low birth weight and fetal programming of cardiovascular diseases in later life. [23] [24] [25] Mechanisms of maternal genetic influence on fetal growth might include placental development, blood supply and nutrient transport. The NO system is known to be involved in those processes. 26 As a second aspect of this study, we analysed the influence of maternal NOS3 polymorphisms on fetal outcomes such as birth weight and congenital malformations.
Methods

Subjects and data collection
From January 2000 to September 2002, all Caucasian women delivering in the Charité obstetrics department in Berlin/Germany (n ¼ 2316) were invited to take part in this study. The local ethics committee approved the study. In all, 5.6% of the women refused to participate (remaining n ¼ 2186). After written consent, a structured interview was performed. German guidelines for medical follow-up in pregnancy comprise a standardized document containing essential data about the current pregnancy. The following data were extracted into our database: age, body height, weight before (self-reported) and during pregnancy, gravidity, duration of pregnancy, urine dipstick results, clinical evaluation of oedema by experienced gynaecologists and BP readings at all follow-up visits in seated position by physicians or obstetrical nurses via auscultatory method using a mercury or aneroid sphygmomanometre (6-23 measurements depending on the number of visits). Korotkoff phase V was generally used for defining diastolic BP. When sounds were audible with the cuff deflated, Korotkoff phase IV was used instead. Blood for genotyping was taken from a cubital vein after delivery. The women were classified according to previously published definitions. 27 Gestational hypertension was defined as BP 4140 mm Hg systolic or 490 mm Hg diastolic in at least two separate recordings after week 20 of pregnancy in women who were normotensive before. Pre-eclampsia was assumed in women with gestational hypertension and protein X1 þ in a random urine dipstick determination with no evidence of urinary tract infection and negative dipstick results before week 20. Women with pre-existing hypertension and new protein excretion X1 þ were classified as pre-eclampsia superimposed on chronic hypertension. For all individuals, mean BP was calculated for each trimester (mean number of available readings: 1.8, 4.0 and 5.5). Only nitrate-negative urine dipstick results were analysed. Oedema is not relevant for the classification of hypertensive disorders of pregnancy anymore. New-onset oedema in the Abbreviation: NOS3, nitric oxide synthase gene.
Nitric oxide synthase gene and pregnancy B Hocher et al second half of pregnancy (after week 20) was nonetheless analysed as it is often clinically associated with pre-eclampsia and possibly results from the same pathophysiology. In all, 554 of all newborns were referred to the neonatal intensive care unit of the Charité after delivery. Routinely, all International Classification of Diseases-10th Revision diagnostic codes of these newborns are entered into a database by neonatologists. All codes concerning congenital malformations and deformations (Q00-Q89) but not chromosomal abnormalities were extracted. The presence of any congenital malformation and major subgroups of malformations with a total of at least 18 cases were further analysed for associations with NOS3 polymorphisms.
Genetic analysis
Genotyping was performed in the first 1502 women for the G894T and T789C polymorphisms to obtain groups large enough to statistically detect BP differences of about 1.5 mm Hg. Because of the low prevalence of the VNTR 4a variant, all 2186 women had to be genotyped for the VNTR 4a/b polymorphism to achieve this goal.
Genomic DNA was isolated from peripheral white blood cells as described previously. 28 Genotypes for the G894T polymorphism were determined by PCR using primers 5 0 -CATGAGGCTCAGCCCCAGAAC-3 MgCl 2 and 5 U ml À1 Taq DNA polymerase (Bioron). DNA fragments were run on a 2.5% agarose gel followed by ethidium bromide staining and ultraviolet transillumination. All genotyping was perfomed blinded and at least twice. Only matching results from separate experiments were accepted.
Statistical analysis
Data were analysed with SPSS version 11.5 (Chicago, IL, USA). Haplotype frequency estimation was performed using PHASE version 2.1.1. 29 Results of continuous variables are expressed as mean±s.d. Pearson's goodness-of-fit w 2 was used for testing deviation from Hardy-Weinberg equilibrium. Analysis of variance was used for comparison of continuous variables between groups. Categorical data were compared using Pearson's w 2 test. Age, body mass index (BMI, before pregnancy), twin pregnancies and primigravidity are known to influence BP in pregnancy. Therefore, all BP comparisons were additionally performed by analysis of covariance including those parameters as covariates. The sample size and frequency of alleles reported in this study allow to detect BP differences of about 1.5 mm Hg with power 0.8 between the groups homozygous for the common alleles and the respective heterozygous groups. All tests are two-sided and P-values o0.05 are considered significant.
Results
Descriptive data of the study population are shown in Table 2 .
Genotype distributions of the NOS3 polymorphisms are shown in Table 3 .
Comparison of descriptive data (Table 2 ) between the genotypes revealed the following difference for diabetes during pregnancy: G894T GG 1.9% (of 737), GT 4.2% (of 647), TT 4.9% (of 118) (P ¼ 0.04). All other characteristics of Table 2 were not significantly different between the genotypes (data not shown).
There were no significant differences in mean systolic or diastolic BP, protein excretion or new-onset peripheral oedema between any of the Table 4 . Also, the mean individual systolic and diastolic BP rise from the first to the last trimester of pregnancy was not significantly different between the genotypes (data not shown). All calculations of Table 4 were also performed assuming a dominant or recessive mode of inheritance for all alleles: Classification according to the above-stated definitions adds up to 106 women with gestational hypertension (4.8%), 36 women with pre-eclampsia (1.6%) and 42 women with pre-eclampsia superimposed on chronic hypertension (2.0%). As expected, the study is thus underpowered to detect small genotypic risks for binary outcomes. There were no significant differences of gestational hypertension or pre-eclampsia between any of the genotypes as shown in Table 4 .
To identify possible synergistic effects, we analysed all combinations of the NOS3 genotypes and corrected the results for multiple testing according to the Bonferroni method. The concomitant presence of any allele of the NOS3 variants was neither associated with elevated BP, proteinuria or oedema, nor with the diagnosis of gestational hypertension or pre-eclampsia (data not shown).
Haplotype analysis revealed the following frequency of individuals with at least one haplotype allele: G894/T786/4b 77.9%, T894/C786/4b 31.4%, G894/C786/4a 25.8%, T894/T786/4b 23.1%, G894/ C786/4b 5.7%, G894/T786/4a 4.1%, T894/C786/4a 0.2% and T894/T786/4a 0%. Only individuals genotyped for all three polymorphisms were considered in this analysis (n ¼ 1502). Detailed analysis of the most frequent haplotypes (45%) revealed no associations of a particular haplotype with BP, Abbreviations: ANCOVA, analysis of covariance; VNTR 4a/b, variable number of tandem repeats polymorphism in intron 4. P-values for blood pressure comparisons are adjusted for age, body mass index before pregnancy, twin pregnancies and primigravidity in an ANCOVA. Categorical data were compared using Pearson's w 2 test. Data are given as mean ± s.d. or percentage.
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There was no association between any of the maternal NOS3 genotypes and birth weight or the incidence of congenital malformations as shown in Tables 5 and 6 . Circulatory system malformations were mainly atrial and ventricular septal defects and patent ductus arteriosus. Urinary system malformations were mainly malformations of kidney and obstructive defects of renal pelvis and ureter. Musculo-skeletal system malformations were mainly deformities of hip and feet.
Discussion
The aim of the present study was to test the hypothesis of a genetically determined NO-dependent pathogenesis of hypertensive disorders of pregnancy by analysing effects of three maternal candidate polymorphisms of the NOS3 gene (G894T, T789C and VNTR 4a/b) on classic markers of preeclampsia (BP, protein excretion, oedema) rather than binary outcomes such as pre-eclampsia itself. The study included a large number of cases to focus on clinically measurable effects in a population of women with mostly normal pregnancies. Assuming that effects of the polymorphisms (for example, on BP and uteroplacental blood flow) are relevant for all pregnant women, all consecutively included cases were analysed together. The frequencies of alleles in this study do not differ significantly from previous findings in German and other Caucasian populations. 30, 31 In contrast to the above-stated pathophysiological considerations and several case-control studies on hypertensive disorders of pregnancy (Table 1) , the results of this study suggest that there is no association between any of the rare alleles of the maternal NOS3 variants and markers of pre-eclampsia during pregnancy. Also, combinations of the rare alleles do not seem to influence those markers. However, despite our large study population, subgroups of combinations of genotypes might not be large enough for reliable statistical analyses.
Ethnicity plays an important role in genetic association studies. Our results are in line with all case-control studies done on the G894T polymorphism in Caucasian populations (Table 1) . Two recent meta-analyses did not find any associations between the T894 allele and hypertensive disorders of pregnancy, thus supporting our results. 32, 33 Few studies have so far addressed the T789C and VNTR 4a/b variants in this context. Only one recently published study found a weak correlation between the C786 allele and pre-eclampsia (in a Caucasian population). 20 A small study in a Hispanic population found an association between the VNTR 4a allele and pre-eclampsia. 34 All other studies are in line with our findings. 9, 15 We can only speculate about the reason for positive results in some of the studies. Ethnicity certainly plays an important role. But even small differences of unknown characteristics of the studied populations may influence the results as Intrauterine growth restriction was found in mice treated with NO synthase inhibitors and mice deficient in endothelial NO synthase. 35, 36 Maternal nitrite/nitrate plasma levels have been found to be decreased in pregnancies with intrauterine growth restriction. 37, 38 Treatment with the NO donor L-arginine was able to increase birth weight in those cases. 38, 39 A small study reported that fetuses of women with at least one rare allele of the NOS3 VNTR 4a/b polymorphism weigh less at birth. 40 According to the results from our large study population, the analysed maternal NOS3 polymorphisms do not influence fetal growth and birth weight.
Exposure of pregnant rodents to non-selective NO synthase inhibitors has been linked to congenital limb reduction and axial skeletal defects. 35, 41 Similar defects have been described in mice deficient in endothelial NO synthase, 36, 42 but not in other NO synthase isoforms. An association between the NOS3 A922G polymorphism and orofacial clefts has been reported. 43 In the present study, we do not find any effect of the maternal NOS3 variants on the incidence of overall cardiovascular, urinary or musculo-skeletal malformations. However, this finding needs to be verified and analysed in more detail in a larger case-control study as the number of cases with for example, limb defects and orofacial clefts was too small for statistical analysis.
In summary, this study demonstrates in a large Caucasian population that maternal NOS3 polymorphisms (G894T, T789C and VNTR 4a/b) are not related to BP regulation, protein excretion and oedema during pregnancy.
In contrast to pathophysiological considerations and the results of several much smaller case-control studies, the functional relevance of the maternal NOS3 variants alone does not seem to be strong enough to produce clinically measurable effects in pregnant women and their newborns.
